Page last updated: 2024-09-04

ezetimibe and Fibrosis

ezetimibe has been researched along with Fibrosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, K; Honda, M; Kaneko, S; Kato, K; Kita, Y; Misu, H; Mizukoshi, E; Nakamura, M; Ota, T; Sunagozaka, H; Takamura, T; Takeshita, Y; Yamada, K; Yamashita, T; Zen, Y1
Guo, Y; Liang, Y; Liu, S; Ren, Q; Wang, X; Wu, T1
Fujii, H; Kawada, N; Ogawa, T; Yoshizato, K1
Acton, S; Braun, A; Broschat, KO; Krieger, M; Krul, ES; Napawan, N; Stagliano, N; Yesilaltay, A1

Trials

1 trial(s) available for ezetimibe and Fibrosis

ArticleYear
The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial.
    Diabetologia, 2014, Volume: 57, Issue:5

    Topics: Aged; Anticholesteremic Agents; Area Under Curve; Azetidines; Biopsy; Carnitine; Cholesterol; Ezetimibe; Fatty Acids; Female; Fibrosis; Gene Expression Profiling; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Liver; Male; Middle Aged; Myofibroblasts; Non-alcoholic Fatty Liver Disease; Oligonucleotide Array Sequence Analysis; Signal Transduction; Transaminases; Treatment Outcome

2014

Other Studies

3 other study(ies) available for ezetimibe and Fibrosis

ArticleYear
Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice.
    Molecular medicine reports, 2014, Volume: 10, Issue:6

    Topics: Acetyl-CoA Carboxylase; Animals; Anticholesteremic Agents; Azetidines; CD36 Antigens; Diet, High-Fat; Ezetimibe; Fatty Acids; Fibrosis; Hyperinsulinism; Insulin Resistance; Lipid Metabolism; Lipogenesis; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Stearoyl-CoA Desaturase

2014
A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits.
    The American journal of pathology, 2010, Volume: 177, Issue:1

    Topics: Animals; Anticholesteremic Agents; Antioxidants; Azetidines; Cholesterol, Dietary; Diet; Dietary Fats; Disease Models, Animal; Ezetimibe; Fatty Liver; Fibrosis; Gene Expression Profiling; Glucose; Humans; Liver; Male; Microarray Analysis; Molecular Sequence Data; Oxidative Stress; Rabbits

2010
Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice.
    Atherosclerosis, 2008, Volume: 198, Issue:1

    Topics: Animals; Anticholesteremic Agents; Apolipoproteins E; Azetidines; Bile Acids and Salts; Body Weight; Cardiomegaly; Cholesterol; Coronary Artery Disease; Cyclic N-Oxides; Disease Models, Animal; Eating; Ezetimibe; Female; Fibrosis; Hypercholesterolemia; Intestinal Absorption; Life Expectancy; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Scavenger Receptors, Class B; Survival Rate; Triglycerides; Tropanes

2008